Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis

Thrombosis Research

Volumn 52, Issue 2, 1988, Pages 165-171

  Matsuo, Takefumi ^a   Chikahira, Yoshimi ^a   Yamada, Tsutomu ^a   Nakao, Kazukiy ^a   Ueshima, Shigeru ^b   Matsuo, Osamu ^b  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemodialysis; Heparin; Thrombin inhibitor; Thrombocytopenia

Indexed keywords

ARGATROBAN; HEPARIN;

HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

BLOOD PLATELETS; HEPARIN; HUMAN; IMMUNOGLOBULIN G; PIPECOLIC ACIDS; PLATELET AGGREGATION; RENAL DIALYSIS; THROMBIN; THROMBOCYTOPENIA;

EID: 0023709275     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(88)90095-3     Document Type: Article

References (11)

1. Aspirin prevents heparin-induced platelet aggregation in vivo
2. Effect of low-molecular-weight heparin on platelets as compared with commercial heparin
3. Effect of a new anticoagulant (MD805) on platelet activation in the hemodialysis circuit
4. Thrombosis and thrombocytopenia induced by heparin
5. A diagnostic test for heparin-induced thrombocytopenia
6. Plasma antithrombin activity of MD805 determined by chromogenic substrate during hemodialysis
7. Heparin-induced thrombocytopenia: Effect of heparin platelet antibody on platelets
8. Heparin-associated thrombocytopenia
9. An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin
10. Heparin associated thrombocytopenia: antibody binding specificity to platelet antigens
11. Heparin-induced thrombocytopenia further studies of the effects of heparin-dependent antibodies on platelets